Restricted accessResearch articleFirst published online 2016-5
A controlled release system for quercetin from biodegradable poly(lactide-co-glycolide)–polycaprolactone nanofibers and its in vitro antitumor activity
Quercetin is a potent natural antioxidant but has limited therapeutic applications due to its short half-life in body fluids. In order to improve the efficacy of quercetin and overcome its shortcomings, quercetin-encapsulated electrospun poly(lactic-co-glycolic acid)–poly(ε-caprolactone) nanofibrous controlled release system was developed using electrospinning technique. Fourier transform infrared spectroscopy, thermogravimetric, and X-ray diffraction analysis suggested the incorporation, thermal stability, and existence of encapsulated quercetin in semicrystalline state in the nanofibers. The release profiles of quercetin from the poly(lactide-co-glycolide)–polycaprolactone nanofibers in phosphate-buffered saline showed controlled release of quercetin up to 120 h. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed an evident inhibition effect of quercetin-encapsulated nanofibers against human hepatocellular carcinoma (HepG2), and the inhibition rate of 29%, 72%, and 80.1% were recorded for 1%, 2%, and 4% quercetin-encapsulated nanofibers, respectively. The formulated drug delivery system could be potentially used as an implantable anticancer drug in clinical applications in the future.
AmjadiIRabieeMHosseiniMS. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Appl Biochem Biotech2012; 168: 1434–1447.
3.
ChenPWuQ-SDingY-P. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro. Eur J Pharm Biopharm2010; 76: 413–420.
VashisthPSharmaMNikhilK. Antiproliferative activity of ferulic acid-encapsulated electrospun PLGA/PEO nanofibers against MCF-7 human breast carcinoma cells. 3 Biotech2015; 5: 303–315.
6.
DavisCDMilnerJA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem2010; 20: 743–752.
7.
TanBLiuYChangK. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int J Nanomedicine2012; 7: 651–661.
8.
ZhangHZhangMYuL. Antitumor activities of quercetin and quercetin-5′,8-disulfonate in human colon and breast cancer cell lines. Food Chem Toxicol2012; 50: 1589–1599.
9.
NathiyaSDurgaMDevasenaT. Quercetin, Encapsulated quercetin and its applications—a review. Int J Pharm Pharm Sci2014; 6: 20–26.
KangTLiangM. Studies on the inhibitory effects of quercetin on the growth of HL460 leukemia cells. Biochem Pharmacol1997; 54: 1013–1018.
12.
SuhDKLeeEJKimHC. Induction of G(1)/S phase arrest and apoptosis by quercetin in human osteosarcoma cells. Arch Pharm Res2010; 33: 781–785.
13.
D’ArchivioMFilesiCVarìR. Bioavailability of the polyphenols: status and controversies. Int J Mol Sci2010; 11: 1321–1342.
14.
VashisthPNikhilKPemmarajuSC. Antibiofilm activity of quercetin-encapsulated cytocompatible nanofibers against Candida albicans. J Bioact Compat Poly2013; 28: 652–665.
15.
VashisthPPruthiPASinghRP. Process optimization for fabrication of gellan based electrospun nanofibers. Carbohyd Polym2014; 109: 16–21.
16.
MosmannT. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods1983; 65: 55–63.
17.
KumariAYadavSKPakadeYB. Nanoencapsulation and characterization of Albizia chinensis isolated antioxidant quercitrin on PLA nanoparticles. Colloid Surface B2011; 82: 224–232.
18.
YangYLiXQiM. Release pattern and structural integrity of lysozyme encapsulated in core-sheath structured poly(DL-lactide) ultrafine fibers prepared by emulsion electrospinning. Eur J Pharm Biopharm2008; 69: 106–116.
19.
WilliamsonGManachC. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr2005; 81: 243S–255S.
20.
PoolHQuintanarDFigueroaJDD. Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. J Nanomater2012; 2012: 1–12.
21.
AmnaTHassanMSBarakatNAM. Antibacterial activity and interaction mechanism of electrospun zinc-doped titania nanofibers. Appl Microbiol Biot2012; 93: 743–751.
22.
PralhadTRajendrakumarK. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal2004; 34: 333–339.
23.
BorghettiGSLulaISSinisterraRD. Quercetin/beta-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture. AAPS PharmSciTech2009; 10: 235–242.
24.
SannaVRoggioAMPosadinoAM. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies. Nanoscale Res Lett2011; 6: 260–269.
25.
XuXXChenXLuT. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells. J Control Release2006; 114: 307–316.
26.
KimHMoonJAhnK. Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells. Oxid Med Cell Longev2013; 2013: 1–10.
ParkCHChangJYHahmER. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun2005; 328: 227–234.
29.
DengX-HSongH-YZhouY-F. Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp Ther Med2013; 6: 1155–1158.
30.
AvilaMAVelascoJANotarloV. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res1994; 54: 2424–2428.
31.
JaramilloSLopezSVarelaLM. The flavonol isorhamnetin exhibits cytotoxic effects on human colon cancer cells. J Agric Food Chem2010; 58: 10869–10875.
32.
ChanS-TYangN-CHuangC-S. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. PLoS ONE2013; 8: e54255.
33.
NiuGYinSXieS. Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells. Acta Biochim Biophys Sin2011; 43: 30–37.
